$60,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Provide strategic counsel and advocate on issues related to medical device regulation."
You can find more data on corporate lobbying on Quiver Quantitative.
BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BDX Insider Trading Activity
BDX insiders have traded $BDX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- MICHAEL DAVID GARRISON (EVP & Pres Med.Essntl&BioPharm) has made 0 purchases and 3 sales selling 2,239 shares for an estimated $457,308.
- BERTRAM L SCOTT has made 0 purchases and 2 sales selling 1,170 shares for an estimated $212,345.
- MICHAEL FELD (EVP, Chief Revenue Officer) has made 0 purchases and 6 sales selling 431 shares for an estimated $80,219.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BDX Hedge Fund Activity
We have seen 587 institutional investors add shares of BDX stock to their portfolio, and 789 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AUTO-OWNERS INSURANCE CO removed 40,501,260 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $6,303,616,106
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 6,005,889 shares (-37.0%) from their portfolio in Q4 2025, for an estimated $1,165,562,878
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,568,558 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $886,620,051
- VANGUARD GROUP INC added 4,223,149 shares (+13.0%) to their portfolio in Q4 2025, for an estimated $819,586,526
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 4,137,888 shares (+23219.2%) to their portfolio in Q4 2025, for an estimated $803,039,924
- GENERATION INVESTMENT MANAGEMENT LLP removed 1,984,672 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $385,165,295
- JPMORGAN CHASE & CO removed 1,794,165 shares (-33.9%) from their portfolio in Q4 2025, for an estimated $348,193,601
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 12 analysts offer price targets for $BDX in the last 6 months, with a median target of $185.0.
Here are some recent targets:
- Jason Bednar from Piper Sandler set a target price of $159.0 on 04/17/2026
- David Roman from Goldman Sachs set a target price of $167.0 on 04/10/2026
- David Toung from Argus Research set a target price of $180.0 on 03/23/2026
- Matt Miksic from Barclays set a target price of $202.0 on 02/11/2026
- Joanna Wiensch from Citigroup set a target price of $198.0 on 02/11/2026
- Matthew Taylor from Jefferies set a target price of $190.0 on 02/10/2026
- Robert Marcus from JP Morgan set a target price of $175.0 on 02/10/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
